FDA UNTITLED_LETTER - Unknown Company - June 12, 2017

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore this company

Record Details

This UNTITLED LETTER record concerns null, with an inspection on June 12, 2017, issued by the Division of Pharmaceutical Quality Operations I, covering drugs.

Inspection Date: June 12, 2017
Product Type: Drugs
Office: Division of Pharmaceutical Quality Operations I
People: Steven E. Porter (Program Division Director)
Karen L. Muir (Ms.)
William V. Millar (Self-employed)

Open in Dashboard

ID · cda8816a-f3d1-467f-878f-2c954f5c2799

Violation Codes6

FD&C Act 501(a)(2)(A)21 U.S.C. 352(f)(1)21 U.S.C. 351(a)(2)(B)21 U.S.C. 353a21 U.S.C. 355(a)21 U.S.C. 331(k)

Full citation text and observation details available on the Dashboard.